Matthews International Capital Management LLC Adagene Inc. Transaction History

Matthews International Capital Management LLC

  • $499 Million
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022
SELL
$1.99 - $3.85 $563,259 - $1.09 Million
-283,045 Reduced 43.68%
364,955 $734,000
Q1 2022

May 05, 2022
SELL
$3.5 - $8.79 $558,600 - $1.4 Million
-159,600 Reduced 19.76%
648,000 $2.31 Million
Q4 2021

Feb 02, 2022
SELL
$7.4 - $14.44 $29,600 - $57,760
-4,000 Reduced 0.49%
807,600 $6.47 Million
Q3 2021

Nov 08, 2021
SELL
$12.7 - $20.68 $341,630 - $556,292
-26,900 Reduced 3.21%
811,600 $11.8 Million
Q1 2021

May 06, 2021
BUY
$17.0 - $29.99 $14.3 Million - $25.1 Million
838,500 New
838,500 $15.1 Million

Others Institutions Holding ADAG

# of Institutions
17
Shares Held
10.9M
Call Options Held
0
Put Options Held
0
View Full List

About Adagene Inc.

ADAG Quotes by TradingView
  • Ticker ADAG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,423,200
  • Market Cap $123M
  • Description
  • Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...
More about ADAG
Track This Portfolio

Track Matthews International Capital Management LLC Portfolio

Follow Matthews International Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matthews International Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matthews International Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email